Literature DB >> 1846394

Hepatitis C virus infection in chronic hepatitis B virus carriers.

G Fattovich1, A Tagger, L Brollo, G Giustina, P Pontisso, G Realdi, A Alberti, A Ruol.   

Abstract

One hundred eighty-four patients with hepatitis B surface antigen-positive chronic hepatitis were evaluated for antibodies to hepatitis C virus (anti-HCV). Only 11 (8%) of 136 patients with hepatitis B virus (HBV) replication (HBV-DNA-positive in serum) while 7 (35%) of 20 positive for antibody to hepatitis B e antigen (anti-HBe) but HBV-DNA-negative were positive for anti-HCV. By contrast, anti-HCV was never found in 30 anti-HBe-positive "healthy" carriers. Anti-HCV was more frequent in hepatitis D virus (HDV)-positive than in HDV-negative cases (32% vs. 12%). During 1-11 years of follow-up, anti-HCV persisted in 90% of cases, who showed continuing alanine aminotransferase elevation. Liver histology deteriorated in 2 of 4 anti-HCV-positive, anti-HBe-positive, HBV-DNA-negative patients. These results demonstrate the existence of a subgroup of patients with anti-HBe-positive, HBV-DNA-negative, HDV-negative chronic hepatitis B, where HCV may play a leading role in causing liver disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1846394     DOI: 10.1093/infdis/163.2.400

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  31 in total

1.  Hepatitis C virus (HCV) and hepatitis B virus (HBV) can coinfect the same hepatocyte in the liver of patients with chronic HCV and occult HBV infection.

Authors:  E Rodríguez-Iñigo; J Bartolomé; N Ortiz-Movilla; C Platero; J M López-Alcorocho; M Pardo; I Castillo; V Carreño
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 2.  Hepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals.

Authors:  Jacinta A Holmes; Ming-Lung Yu; Raymond T Chung
Journal:  Expert Opin Drug Saf       Date:  2017-05-19       Impact factor: 4.250

Review 3.  Management of chronic hepatitis B in patients from special populations.

Authors:  Ching-Lung Lai; Man-Fung Yuen
Journal:  Cold Spring Harb Perspect Med       Date:  2015-06-01       Impact factor: 6.915

4.  Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines.

Authors:  Carla S Coffin; Scott K Fung; Mang M Ma
Journal:  Can J Gastroenterol       Date:  2012-12       Impact factor: 3.522

5.  Seropositivity of hepatitis B virus and hepatitis C virus dual infection among blood donors in Nyala teaching hospital.

Authors:  Mustafa Abdalla Ali Abou; Yassir Mohammed Eltahir
Journal:  Virol J       Date:  2009-12-22       Impact factor: 4.099

6.  Dual chronic hepatitis B virus and hepatitis C virus infection.

Authors:  Chun-Jen Liu; Pei-Jer Chen; Ding-Shinn Chen
Journal:  Hepatol Int       Date:  2009-08-08       Impact factor: 6.047

Review 7.  Hepatitis C virus superinfection in patients with chronic hepatitis B virus infection.

Authors:  Yun-Fan Liaw
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

8.  Hepatitis C virus infection: its role in chronic liver diseases.

Authors:  Y Y Zhang; L S Guo; Y D Zhang; L Li; D X Yu; F H Li; Y K Wang; Z Q Yu; L J Hao; B G Hansson
Journal:  J Tongji Med Univ       Date:  1993

9.  Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells.

Authors:  C M Shih; S J Lo; T Miyamura; S Y Chen; Y H Lee
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

10.  Hepatitis C virus infection in patients with acute hepatitis B.

Authors:  M Rodríguez; C A Navascués; A Martínez; A Suárez; N G Sotorrío; R Cimadevilla; A Linares; R Pérez; L Rodrigo
Journal:  Infection       Date:  1992 Nov-Dec       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.